Increased covalent conjugation of a model antigen to poly(lactic acid)-g-maleic anhydride nanoparticles compared to bare poly(lactic acid) nanoparticles

Colloid and Polymer Science

Volumn 291, Issue 12, 2013, Pages 2775-2781

  Orozco, Víctor H ^a   Palacio, Juliana ^a   Sierra, Jelver ^a   López, Betty L ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

(Zeta) ? potential; 1HNMR; Adsorption; Chemical conjugation; Grafting; Maleic anhydride; Ovalbumin; PLAnanoparticles

Indexed keywords

ADSORPTION; AMIDES; COLLOIDS; LACTIC ACID; LIGHT SCATTERING; MALEIC ANHYDRIDE; NANOPARTICLES; PARTICLE SIZE; PROTEINS;

1HNMR; CARBOXYLIC ACID GROUPS; COLLOIDAL DISPERSION; NANO-PARTICLE DISPERSIONS; OVALBUMINS; PLANANOPARTICLES; POLYMERIC NANOPARTICLES; PROTON NUCLEAR MAGNETIC RESONANCE;

GRAFTING (CHEMICAL);

ANTIGEN; MALEIC ANHYDRIDE; NANOPARTICLE; OVALBUMIN; POLY(LACTIC ACID)GAMMA MALEIC ANHYDRIDE; POLYLACTIC ACID; PROTON; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CONJUGATION; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADICAL REACTION; SYNTHESIS;

EID: 84892372389     PISSN: 0303402X     EISSN: 14351536     Source Type: Journal    
DOI: 10.1007/s00396-013-3023-9     Document Type: Article

References (65)

1. Atkins H (2010) Hematopoietic SCT for the treatment of multiple sclerosis. Bone Marrow Transplant 45(12):1671-1681
2. Chilcott J, Lloyd Jones M, Wilkinson A (2009) Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal. Health Technol Assess 13(Suppl 1):7-13
3. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54(5):631-651
4. Cirstoiu-Hapca A, Bossy-Nobs L, Buchegger F, Gurny R, Delie F (2007) Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles. Int J Pharm 331(2):190-196
5. Girard MP, PreziosiM-P, AguadoM-T, Kieny MP (2006)A review of vaccine research and development: meningococcal disease. Vaccine 24(22):4692-4700. doi:10.1016/j.vaccine.2006.03.034
6. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP (2005) Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57(3):391-410. doi:10.1016/j.addr.2004.09.003
7. des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116(1):1-27
8. Akagi T, Baba M, Akashi M (2012) Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine polymers in nanomedicine. In: Kunugi S, Yamaoka T (eds) Advances in polymer science, 247th edn. Springer, Berlin, pp 31-64. doi:10.1007/12-2011-150
9. Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA (2010) Polymeric particles in vaccine delivery. Curr Opin Microbiol 13(1):106-112. doi:10.1016/j.mib.2009.12.001
10. Plapied L, Duhem N, des Rieux A, Préat V (2011) Fate of polymeric nanocarriers for oral drug delivery. Curr Opin Colloid Interface Sci 16:228-237
11. Jain AK, Goyal AK, Gupta PN, Khatri K, Mishra N, Mehta A, Mangal S, Vyas SP (2009) Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release 136(2):161-169
12. Kazzaz J, Neidleman J, Singh M, Ott G, O'Hagan DT (2000) Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Control Release 67(2-3):347-356
13. Bajpai AK, Shukla SK, Bhanu S, Kankane S (2008) Responsive polymers in controlled drug delivery. Prog Polym Sci 33(11):1088-1118. doi:10.1016/j. progpolymsci.2008.07.005
14. Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B 75(1):1-18
15. Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E (2004) Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 21(8):1428-1439
16. Jung T, Kamm W, Breitenbach A, Hungerer K-D, Hundt E, Kissel T (2001) Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res 18(3):352-360
17. Diwan M, Elamanchili P, Lane H, Gainer A, Samuel J (2003) Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary Tcell responses. J Drug Target 11(8-10):495-507. doi:10.1080/10611860410001670026
18. Tafaghodi M, Khamesipour A, Jaafari M (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitol Res 108(5):1265-1273. doi:10.1007/s00436-010-2176-4
19. Xiao RZ, Zeng ZW, Zhou GL (2010) Recent advances in PEG-PLA block copolymer nanoparticles. Int J Nanomedicine 5(1):1057-1065
20. Narayanan S, Binulal NS, Mony U, Manzoor K, Nair S, Menon D (2010) Folate targeted polymeric 'green' nanotherapy for cancer. Nanotechnology 21(28):1-13
21. El Fagui A, Amiel C (2012) PLA nanoparticles coated with a β-cyclodextrin polymer shell: preparation, characterization and release kinetics of a hydrophobic compound. Int J Pharm 436(1-2):644-651. doi:10.1016/j.ijpharm.2012.07.052
22. Khalil NM, Nascimento TCF, Casa DM, Dalmolin LF, Mattos AC, Hoss I, Romano MA, Mainardes RM (2013) Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B 101(0):353-360. doi:10. 1016/j.colsurfb.2012.06.024
23. Leila N, Franz B, Robert G, Eric A (2004) Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci 93(8):1980-1992
24. Wendorf J, Singh M, Chesko J, Kazzaz J, Soewanan E, Ugozzoli M, O'Hagan D (2006) A practical approach to the use of nanoparticles for vaccine delivery. J Pharm Sci 95(12):2738-2750
25. Jain AK, Goyal AK, Mishra N, Vaidya B, Mangal S, Vyas SP (2010) PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharm 387(1-2):253-262
26. Lamalle-Bernard D, Munier S, Compagnon C, Charles M-H, Kalyanaraman VS, Delair T, Verrier B, Ataman-Önal Y (2006) Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity. J Control Release 115(1):57-67
27. Ataman-Önal Y, Munier S, Ganée A, Terrat C, Durand P-Y, Battail N, Martinon F, Le Grand R, Charles M-H, Delair T, Verrier B (2006) Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Release 112(2):175-185. doi:10.1016/j.jconrel.2006.02.006
28. Gupta AP, Kumar V (2007) New emerging trends in synthetic biodegradable polymers -polylactide: a critique. Eur Polym J 43(10): 4053-4074
29. Ogier J, Arnauld T, Doris E (2009) Recent advances in the field of nanometric drug carriers. Futur Med Chem 1(4):693-711
30. Xiong L, He Z (2010) The biological evaluation of the PEG/PLA amphiphilic diblock copolymer. Polym-Plast Technol Eng 49(12): 1201-1206
31. Fredenberg S, Wahlgren M, Reslow M, Axelsson A (2011) The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems -A review. Int J Pharm 415(1-2):34-52. doi:10.1016/j.ijpharm.2011.05.049
32. Xu F, Yuan Y, Shan X, Liu C, Tao X, Sheng Y, Zhou H (2009) Longcirculation of hemoglobin-loaded polymeric nanoparticles as oxygen carrierswithmodulated surface charges. Int J Pharm 377(1-2):199-206
33. Goddard JM, Hotchkiss JH (2007) Polymer surface modification for the attachment of bioactive compounds. Prog Polym Sci 32(7):698-725
34. Garlotta D (2001) A literature review of poly(lactic acid). J Polym Environ 9(2):63-84. doi:10.1023/a:1020200822435
35. Luo YF, Wang YL, Niu XF, Pan J, Shi LP (2004) Synthesis and characterization of novel biomaterial: maleic anhydride-modified poly(DL-lactic acid). Chin Chem Lett 15:521-524
36. Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6(4):319-327
37. Chen S, Pieper R, Webster DC, Singh J (2005) Triblock copolymers: synthesis, characterization, and delivery of a model protein. Int J Pharm 288(2):207-218
38. Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C (1999) Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release 60(2-3):179-188
39. Illum L, Jones PDE, Kreuter J, Baldwin RW, Davis SS (1983) Adsorption of monoclonal antibodies to polyhexylcyanoacrylate nanoparticles and subsequent immunospecific binding to tumour cells in vitro. Int J Pharm 17(1):65-76
40. Del Gaudio P, Russo P, Lauro MR, Colombo P, Aquino RP (2009) Encapsulation of ketoprofen and ketoprofen lysinate by prilling for controlled drug release. AAPS PharmSciTech 10(4):1178-1185. doi:10.1208/s12249-009-9309-z
41. Labouta HI, El-Khordagui LK, Molokhia AM, Ghaly GM (2009) Multivariate modeling of encapsulation and release of an ionizable drug from polymer microspheres. J Pharm Sci 98(12):4603-4615. doi:10.1002/jps.21753
42. Gasparini G, Holdich RG, Kosvintsev SR (2010) PLGA particle production for water-soluble drug encapsulation: degradation and release behaviour. Colloids Surf B 75(2):557-564. doi:10.1016/j. colsurfb.2009.09.035
43. Karanikolopoulos N, Zamurovic M, Pitsikalis M, Hadjichristidis N (2009) Poly(DL-lactide)-b-poly(N,N-dimethylamino-2-ethyl methacrylate): synthesis, characterization, micellization behavior in aqueous solutions, and encapsulation of the hydrophobic drug dipyridamole. Biomacromolecules 11(2):430-438. doi:10.1021/bm901151g
44. Naskar J, Palui G, Banerjee A (2009) Tetrapeptide-based hydrogels: for encapsulation and slow release of an anticancer drug at physiological pH. J Phys Chem B 113(35):11787-11792. doi:10.1021/ jp904251j
45. Jun P, Yuanliang W, Suhua Q, Bingbing Z, Yanfeng L (2005) Grafting reaction of poly(D,L)lactic acid with maleic anhydride and hexanediamine to introduce more reactive groups in its bulk. J Biomed Mater Res Part B 74B(1):476-480
46. Nobs L, Buchegger F, Gurny R, Allémann E (2003) Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups bymeans of three methods. Int J Pharm 250(2):327-337
47. Nobs L, Buchegger F, Gurny R, Allémann E (2004) Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin(TM) for active targeting. Eur J Pharm Biopharm 58(3):483-490
48. Daorat M, Suttireungwong S, Tongpin C (2010) Functionalization of Poly(lactic acid) with maleic anhydride for biomedical application. JMMM 20(3):189-192
49. Paleos CM, Tsiourvas D, Anastassopoulou J, Theophanides T (1992) Supramolecular structure of certain amphiphilic liquid crystalline polymers. Polymer 33(19):4047-4051
50. Tsiourvas D, Paleos CM, Photis D (1989) Functionalized polymers derived from the reaction of polymaleic anhydride with amines and alcohols. J Appl Polym Sci 38(2):257-264
51. Bauminger S, Wilchek M (1980) The use of carbodiimides in the preparation of immunizing conjugates.Methods Enzymol 70:151-159
52. Smith M, Moffatt JG, Khorana HG (1958) Carbodiimides. VIII.1
53. Observations on the reactions of carbodiimides with acids and some new applications in the synthesis of phosphoric acid esters. J Am Chem Soc 80(23):6204-6212. doi:10.1021/ja01556a015
54. Williams A, Ibrahim IT (1981) Carbodiimide chemistry: recent advances. Chem Rev 81(6):589-636. doi:10.1021/cr00046a004
55. Roman BS, Espuelas S, Gomez S, Gamazo C, Sanz ML, Ferrer M, Irache JM (2007) Intradermal immunization with ovalbuminloaded poly-epsilon-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice. Clin Exp Allergy 37(2):287-295
56. Slutter B, Plapied L, Fievez V, SandeMA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W, Preat V (2009) Mechanistic study of the adjuvant effect of biodegradable nanoparticles inmucosal vaccination. J Control Release 138(2):113-121. doi:10.1016/j.jconrel.2009.05.011
57. Palacio J, Orozco VH, López BL (2011) Effect of the molecular weight on the physicochemical properties of poly(lactic acid) nanoparticles and on the amount of ovalbumin adsorption. J Braz Chem Soc 22(12):2304-2311
58. CarlsonD,Nie L,NarayanR,Dubois P (1999) Maleation of polylactide (PLA) by reactive extrusion. J Appl Polym Sci 72(4):477-485
59. Chen L, Qiu X, Xie Z, Hong Z, Sun J, Chen X, Jing X (2006) Poly(L-lactide)/starch blends compatibilized with poly(L-lactide)-g-starch copolymer. Carbohydr Polym 65(1):75-80
60. Joshi RM (1962) The free radical polymerization of maleic anhydride. Die Makromol Chem 53(1):33-45
61. Pan J, Wang Y, Qin S, Zhang B, Luo Y (2005) Grafting reaction of poly(D,L)lactic acid with maleic anhydride and hexanediamine to introduce more reactive groups in its bulk. J Biomed Mater Res B Appl Biomater 74B(1):476-480
62. Orozco VH, Kozlovskaya V, Kharlampieva E, López BL, Tsukruk VV (2010) Biodegradable self-reporting nanocomposite films of poly(lactic acid) nanoparticles engineered by layer-by-layer assembly. Polymer 51(18):4127-4139. doi:10.1016/j.polymer. 2010.06.060
63. Kharlampieva E, Kozlovskaya V, Zavgorodnya O, Lilly GD, Kotov NA, Tsukruk VV (2010) pH-responsive photoluminescent LbL hydrogels with confined quantum dots. Soft Matter 6(4):800-807
64. Kozlovskaya V, Kharlampieva E, Mansfield ML, Sukhishvili SA (2005) Poly(methacrylic acid) hydrogel films and capsules: response to pH and ionic strength, and encapsulation of macromolecules. Chem Mater 18(2):328-336. doi:10.1021/cm0517364
65. Espartero JL, Rashkov I, Li SM, Manolova N, Vert M(1996) NMR analysis of low molecular weight poly(lactic acid)s. Macromolecules 29(10):3535-3539. doi:10.1021/ma950529u